Calmax en es it fr

Calmax Brand names, Calmax Analogs

Calmax Brand Names Mixture

  • No information avaliable

Calmax Chemical_Formula


Calmax RX_link

Calmax fda sheet

Calmax FDA

Calmax msds (material safety sheet)

Calmax Synthesis Reference

R. P. Pioch, U.S. Pat. 4,375,547 (1982)

Calmax Molecular Weight

331.46 g/mol

Calmax Melting Point

203 oC

Calmax H2O Solubility


Calmax State


Calmax LogP


Calmax Dosage Forms

Capsule (150, 300 mg)

Calmax Indication

For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.

Calmax Pharmacology

Nizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers.

Calmax Absorption

Rapid (bioavailability of nizatidine exceeds 70%)

Calmax side effects and Toxicity

Oral, rat LD50: 301 mg/kg. Symptoms of overdose include cholinergic-type effects including lacrimation, salivation, emesis, miosis, and diarrhea.

Calmax Patient Information

Calmax Organisms Affected

Humans and other mammals